Allspring Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.2M Buy
126,540
+18,011
+17% +$8.14M 0.1% 256
2025
Q1
$52.6M Buy
108,529
+11,903
+12% +$5.77M 0.09% 275
2024
Q4
$39.2M Sell
96,626
-139,700
-59% -$56.7M 0.06% 356
2024
Q3
$110M Buy
236,326
+37,399
+19% +$17.4M 0.17% 138
2024
Q2
$93.2M Sell
198,927
-32,529
-14% -$15.2M 0.15% 155
2024
Q1
$96.8M Buy
231,456
+18,113
+8% +$7.57M 0.15% 158
2023
Q4
$86.8M Sell
213,343
-27,711
-11% -$11.3M 0.14% 169
2023
Q3
$83.8M Sell
241,054
-156,611
-39% -$54.5M 0.15% 167
2023
Q2
$140M Sell
397,665
-9,598
-2% -$3.38M 0.22% 104
2023
Q1
$128M Sell
407,263
-45,307
-10% -$14.3M 0.21% 107
2022
Q4
$131M Sell
452,570
-24,631
-5% -$7.11M 0.22% 108
2022
Q3
$138M Buy
477,201
+95,856
+25% +$27.8M 0.24% 89
2022
Q2
$107M Buy
381,345
+68,586
+22% +$19.3M 0.18% 148
2022
Q1
$81.6M Sell
312,759
-22,846
-7% -$5.96M 0.1% 263
2021
Q4
$73.7M Buy
+335,605
New +$73.7M 0.08% 313